Ryman Healthcare issue of performance share rights

NZX RELEASE

23 September 2024


Issue of performance share rights to senior executives of Ryman Healthcare
Limited
Ryman Healthcare Limited (Ryman) advises that it has issued three tranches of performance
share rights (Share Rights) to eligible members of its senior executive team pursuant to
Ryman’s recently established Long-Term Incentive Plan (LTI). The grant of Share Rights was
approved by the Board on 23 September 2024.
The LTI plan will grant eligible members performance rights that will, if hurdles are achieved,
vest as Ryman shares.
The first tranche of 32,592 Share Rights is eligible for vesting over two years (50% on 31
August 2025 and 50% on 31 August 2026). The performance period for the second tranche
of 25,639 Share Rights is 13 November 2023 to 13 November 2026. Vesting of these Share
Rights is conditional upon meeting targets in relation to relative total shareholder return
and absolute total shareholder return. The performance period for the third tranche of
467,130 Share Rights is 1 July 2024 to 30 June 2027. Vesting of these Share Rights is
conditional upon meeting targets in relation to relative total shareholder return and
absolute total shareholder return. In each case, vesting is subject to the relevant holder
remaining an employee of the Ryman Group at the relevant vesting date.
The total number of Share Rights granted is 525,361. No other Share Rights have previously
been granted.
Details of Ryman’s LTI plan can be found on page 127 of the 2024 Annual Report (link).
The attached information is supplied pursuant to NZX Listing Rule 3.13.1.
ENDS
About Ryman:
Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 49
retirement villages in New Zealand and Australia. Ryman villages are home to 14,600
residents, and the company employs 7,700 staff.

Contacts:
For investor relations information contact Hayden Strickett, Head of Investor Relations, on
+64 27 303 1132 or hayden.strickett@rymanhealthcare.com

---

Capital Change Notice





Section 1: Issuer information
Name of issuer Ryman Healthcare Limited
NZX ticker code RYM
Class of financial product Unquoted performance share rights (Share
Rights)
ISIN (If unknown, check on NZX website) NZRYME0001S4
Currency NZD
Section 2: Capital change details
Number issued 525,361
Nominal value (if any) N/A
Issue price per security Nil
Nature of the payment (for example, cash or
other consideration)
No consideration is payable for the grant of the
Share Rights
Amount paid up N/A
Percentage of total class of Financial
Products issued
100% of total Share Rights granted
The principal terms of Conversion Grant of Share Rights pursuant to Ryman’s
Long-Term Incentive Plan.

The Long-Term Incentive Plan will grant eligible
members performance rights that will, if hurdles
are achieved, vest as Ryman shares.

The vesting period for the first tranche of 32,592
Share Rights is 50% on 31 August 2025 and
50% on 31 August 2026. The performance
period for the second tranche of 25,639 Share
Rights is 13 November 2023 to 13 November
2026. Vesting of these Share Rights is
conditional upon meeting targets in relation to
relative total shareholder return and absolute
total shareholder return. The performance
period for the third tranche of 467,130 Share
Rights is 1 July 2024 – 30 June 2027. Vesting of
these Share Rights is conditional upon meeting
targets in relation to relative total shareholder
return and absolute total shareholder return. In
each case, vesting is subject to the relevant
holder remaining an employee of the Ryman
Group at the relevant vesting date.
Reason for issue and specific authority for
issue
Grant of Share Rights pursuant to Ryman’s
Long-Term Incentive Plan, as authorised by the
Board on 23 September 2024.

Total number of Financial Products of the
Class after the issue (excluding Treasury
525,361 Share Rights

Stock) and the total number of Financial
Products of the Class held as Treasury Stock
after the issue.

In the case of an acquisition of shares,
whether those shares are to be held as
treasury stock
N/A
Specific authority for the issue, including a
reference to the rule pursuant to which the
issue is made
Resolutions of the Board and, if the Share
Rights are settled by issuance of new ordinary
shares, NZX Listing Rules 4.6.1 and 4.9.1(b).
Terms or details of the issue (for example:
restrictions, escrow arrangements)
No cash consideration is payable by the
employees on the grant of the Share Rights or
on the delivery of fully paid ordinary shares
following the vesting of Share Rights. Vesting of
the Share Rights is also subject to the
conditions noted above.
Date of issue 23/09/2024
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this
announcement
Rob Woodgate
Contact person for this announcement Rob Woodgate
Contact phone number
+64 27 458 8534

Contact email address Rob.woodgate@rymanhealthcare.com
Date of release through MAP

23/09/2024